Department of Biopathological Sciences and Hygiene of Animal and Alimentary Productions, University of Perugia, Faculty of Veterinary Medicine, Via San Costanza, 4-06126 Perugia, Italy.
Res Vet Sci. 2013 Oct;95(2):310-5. doi: 10.1016/j.rvsc.2013.04.011. Epub 2013 May 10.
Human giant cell tumour of bone (GCTB) is a rare low grade of malignancy tumour with tendency to recur. During tumourigenesis the bone remodeling balance is subverted by the tumour cellular components that interacting with bone matrix induce release of growth factors and cytokines, promoting cell proliferation and bone resorption. The master regulators of this positive feed-back are acid and neutral proteases that destroying extracellular matrix increase osteolysis. In contrast, in cats, very few data are reported on GCTB biological activity. In this study, histological features and metalloproteinase (MMPs) and urokinase plasminogen activator system (uPA) expression were compared in human and feline GCTB and differences in distribution and intensity related to histological pattern and clinical behaviour were determined. In both species, the overexpression of these molecules suggested a strong and complex cross-talk between tumour and microenvironment.
人类巨大细胞瘤(GCTB)是一种罕见的低度恶性肿瘤,有复发倾向。在肿瘤发生过程中,肿瘤细胞成分与骨基质相互作用,导致生长因子和细胞因子的释放,促进细胞增殖和骨吸收,从而破坏骨重塑平衡。这种正反馈的主要调节因子是酸和中性蛋白酶,它们破坏细胞外基质,增加溶骨性。相比之下,在猫中,关于 GCTB 生物学活性的报道很少。在这项研究中,比较了人类和猫的 GCTB 的组织学特征以及基质金属蛋白酶(MMPs)和尿激酶纤溶酶原激活系统(uPA)的表达,并确定了与组织学模式和临床行为相关的分布和强度差异。在这两种物种中,这些分子的过度表达表明肿瘤与微环境之间存在强烈而复杂的相互作用。